Naked Science Forum
Life Sciences => Cells, Microbes & Viruses => Topic started by: binnie on 07/09/2014 04:34:49
-
Which of these drugs will be most effective, the monoclonal antibody cocktail in ZMApp or the two vaccines being promoted by the NIH and the Canadian public health agency?
Drug article: http://www.dddmag.com/articles/2014/09/zmapp-best-anti-ebola-drug-yet Vaccine article:
http://www.nytimes.com/2014/09/06/world/africa/ebola-vaccine-could-be-ready-by-november-who-says.html?_r=0
-
ZMapp and vaccines work differently, ZMapp provides passive immunity to a person already infected and vaccines are given before exposure to induce active immunity so that a person will produce their own antibodies.